10 step control strategy to avoid nitrosamine impurities
Published 2 years ago • 5.8K plays • Length 12:24Download video MP4
Download video MP3
Similar videos
-
8:35
how to decide the need of testing nitrosamine impurities into pharmaceuticals?
-
17:16
how to define limit for newly identified nitrosamine impurity?
-
10:21
is the less than lifetime (ltl) limit applies to nitrosamines?
-
12:37
which limits apply for nitrosamines in medicinal products?
-
15:33
what is the importance of loq in nitrosamine testing?
-
1:00:02
nitrosamine impurities | usp
-
9:13
how to predict the potency category of nitrosamine as per new ema updates
-
42:48
nitrosamine analysis in different sartan and metformin drug formulations by lc-ms/ms
-
4:33
drug development: step by step guide for new medications in 2024
-
16:01
how to do it series - episode 5 - diy biodynamic prep bd508
-
43:45
enhancing nitrosamine control with using a cmc decision support tool
-
41:52
technical tuesday: nitrosamines impurities
-
4:09
nitrosamines risk assessment: step 2
-
17:04
how to define limit for mutagenic impurity in drug product
-
10:38
d1,s4a,s3-exploration of forward-looking ideas for inhibiting nitrosamine formation in drug products
-
0:57
meet corinna, head competence center, global device & packaging development
-
4:18
how to deal with complex nitrosamines?